N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide

C127H186N32O31S — CID 161103430

IUPACN-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide
SMILESCC(C)C(=O)Nc1cncc(-c2cnn(C)c2)c1.CC(C)C(=O)Nc1cncc(OCC(C)(C)CO)n1.CC(C)C(=O)Nc1cncc(OCCC(C)(C)O)n1.CC(C)C(=O)Nc1cncc(OCCCO)n1.CC(C)C(=O)Nc1cncc(OCCO)n1.CC(C)C(=O)Nc1cncc(OC[C@@H](O)CO)c1.CC(C)C(=O)Nc1cncc(OC[C@@H](O)CO)n1.CC(C)C(=O)Nc1cncc(OC[C@H](O)CO)c1.CC(C)C(=O)Nc1cncc(OC[C@H](O)CO)n1.CC(C)C(=O)Nc1cnccn1.Cc1ncc(-c2cncc(NC(=O)C(C)C)c2)s1
InChIInChI=1S/C13H16N4O.2C13H21N3O3.C13H15N3OS.2C12H18N2O4.2C11H17N3O4.C11H17N3O3.C10H15N3O3.C8H11N3O/c1-9(2)13(18)16-12-4-10(5-14-7-12)11-6-15-17(3)8-11;1-9(2)12(18)16-10-5-14-6-11(15-10)19-8-13(3,4)7-17;1-9(2)12(17)16-10-7-14-8-11(15-10)19-6-5-13(3,4)18;1-8(2)13(17)16-11-4-10(5-14-6-11)12-7-15-9(3)18-12;2*1-8(2)12(17)14-9-3-11(5-13-4-9)18-7-10(16)6-15;2*1-7(2)11(17)14-9-3-12-4-10(13-9)18-6-8(16)5-15;1-8(2)11(16)14-9-6-12-7-10(13-9)17-5-3-4-15;1-7(2)10(15)13-8-5-11-6-9(12-8)16-4-3-14;1-6(2)8(12)11-7-5-9-3-4-10-7/h4-9H,1-3H3,(H,16,18);5-6,9,17H,7-8H2,1-4H3,(H,15,16,18);7-9,18H,5-6H2,1-4H3,(H,15,16,17);4-8H,1-3H3,(H,16,17);2*3-5,8,10,15-16H,6-7H2,1-2H3,(H,14,17);2*3-4,7-8,15-16H,5-6H2,1-2H3,(H,13,14,17);6-8,15H,3-5H2,1-2H3,(H,13,14,16);5-7,14H,3-4H2,1-2H3,(H,12,13,15);3-6H,1-2H3,(H,10,11,12)/t;;;;2*10-;2*8-;;;/m....1010.../s1
InChIKeyUISSXJOYZZVCTN-QNYSQKSLSA-N
MW2689.14 g/mol
LogP11.03
Rot. Bonds55

About N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide

N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide (PubChem CID 161103430) has the molecular formula C127H186N32O31S and a molecular weight of 2689.14 g/mol. Its IUPAC name is N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide.

Molecular Properties

Compound NameN-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide
PubChem CID161103430
Molecular FormulaC127H186N32O31S
Molecular Weight2689.14 g/mol
Exact Mass2687.37
IUPAC NameN-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide
SMILESCC(C)C(=O)Nc1cncc(-c2cnn(C)c2)c1.CC(C)C(=O)Nc1cncc(OCC(C)(C)CO)n1.CC(C)C(=O)Nc1cncc(OCCC(C)(C)O)n1.CC(C)C(=O)Nc1cncc(OCCCO)n1.CC(C)C(=O)Nc1cncc(OCCO)n1.CC(C)C(=O)Nc1cncc(OC[C@@H](O)CO)c1.CC(C)C(=O)Nc1cncc(OC[C@@H](O)CO)n1.CC(C)C(=O)Nc1cncc(OC[C@H](O)CO)c1.CC(C)C(=O)Nc1cncc(OC[C@H](O)CO)n1.CC(C)C(=O)Nc1cnccn1.Cc1ncc(-c2cncc(NC(=O)C(C)C)c2)s1
InChIInChI=1S/C13H16N4O.2C13H21N3O3.C13H15N3OS.2C12H18N2O4.2C11H17N3O4.C11H17N3O3.C10H15N3O3.C8H11N3O/c1-9(2)13(18)16-12-4-10(5-14-7-12)11-6-15-17(3)8-11;1-9(2)12(18)16-10-5-14-6-11(15-10)19-8-13(3,4)7-17;1-9(2)12(17)16-10-7-14-8-11(15-10)19-6-5-13(3,4)18;1-8(2)13(17)16-11-4-10(5-14-6-11)12-7-15-9(3)18-12;2*1-8(2)12(17)14-9-3-11(5-13-4-9)18-7-10(16)6-15;2*1-7(2)11(17)14-9-3-12-4-10(13-9)18-6-8(16)5-15;1-8(2)11(16)14-9-6-12-7-10(13-9)17-5-3-4-15;1-7(2)10(15)13-8-5-11-6-9(12-8)16-4-3-14;1-6(2)8(12)11-7-5-9-3-4-10-7/h4-9H,1-3H3,(H,16,18);5-6,9,17H,7-8H2,1-4H3,(H,15,16,18);7-9,18H,5-6H2,1-4H3,(H,15,16,17);4-8H,1-3H3,(H,16,17);2*3-5,8,10,15-16H,6-7H2,1-2H3,(H,14,17);2*3-4,7-8,15-16H,5-6H2,1-2H3,(H,13,14,17);6-8,15H,3-5H2,1-2H3,(H,13,14,16);5-7,14H,3-4H2,1-2H3,(H,12,13,15);3-6H,1-2H3,(H,10,11,12)/t;;;;2*10-;2*8-;;;/m....1010.../s1
InChIKeyUISSXJOYZZVCTN-QNYSQKSLSA-N
XLogP11.03
TPSA899.43 Ų
H-Bond Donors23
H-Bond Acceptors53
Rotatable Bonds55
Heavy Atoms191
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002689.14
LogP ≤ 511.03
H-Bond Donors ≤ 523
H-Bond Acceptors ≤ 1053

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide?
The IUPAC name of N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide (CID 161103430) is N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide.
What is the SMILES notation for N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide?
The canonical SMILES for N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide is CC(C)C(=O)Nc1cncc(-c2cnn(C)c2)c1.CC(C)C(=O)Nc1cncc(OCC(C)(C)CO)n1.CC(C)C(=O)Nc1cncc(OCCC(C)(C)O)n1.CC(C)C(=O)Nc1cncc(OCCCO)n1.CC(C)C(=O)Nc1cncc(OCCO)n1.CC(C)C(=O)Nc1cncc(OC[C@@H](O)CO)c1.CC(C)C(=O)Nc1cncc(OC[C@@H](O)CO)n1.CC(C)C(=O)Nc1cncc(OC[C@H](O)CO)c1.CC(C)C(=O)Nc1cncc(OC[C@H](O)CO)n1.CC(C)C(=O)Nc1cnccn1.Cc1ncc(-c2cncc(NC(=O)C(C)C)c2)s1.
What is the InChIKey of N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide?
The InChIKey is UISSXJOYZZVCTN-QNYSQKSLSA-N. The full InChI is InChI=1S/C13H16N4O.2C13H21N3O3.C13H15N3OS.2C12H18N2O4.2C11H17N3O4.C11H17N3O3.C10H15N3O3.C8H11N3O/c1-9(2)13(18)16-12-4-10(5-14-7-12)11-6-15-17(3)8-11;1-9(2)12(18)16-10-5-14-6-11(15-10)19-8-13(3,4)7-17;1-9(2)12(17)16-10-7-14-8-11(15-10)19-6-5-13(3,4)18;1-8(2)13(17)16-11-4-10(5-14-6-11)12-7-15-9(3)18-12;2*1-8(2)12(17)14-9-3-11(5-13-4-9)18-7-10(16)6-15;2*1-7(2)11(17)14-9-3-12-4-10(13-9)18-6-8(16)5-15;1-8(2)11(16)14-9-6-12-7-10(13-9)17-5-3-4-15;1-7(2)10(15)13-8-5-11-6-9(12-8)16-4-3-14;1-6(2)8(12)11-7-5-9-3-4-10-7/h4-9H,1-3H3,(H,16,18);5-6,9,17H,7-8H2,1-4H3,(H,15,16,18);7-9,18H,5-6H2,1-4H3,(H,15,16,17);4-8H,1-3H3,(H,16,17);2*3-5,8,10,15-16H,6-7H2,1-2H3,(H,14,17);2*3-4,7-8,15-16H,5-6H2,1-2H3,(H,13,14,17);6-8,15H,3-5H2,1-2H3,(H,13,14,16);5-7,14H,3-4H2,1-2H3,(H,12,13,15);3-6H,1-2H3,(H,10,11,12)/t;;;;2*10-;2*8-;;;/m....1010.../s1.
What are the key properties of N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide?
N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide has a molecular weight of 2689.14 g/mol, XLogP of 11.03, 55 rotatable bonds, 23 hydrogen bond donors, and 53 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[(2R)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[6-[(2S)-2,3-dihydroxypropoxy]pyrazin-2-yl]-2-methylpropanamide;N-[5-[(2R)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[5-[(2S)-2,3-dihydroxypropoxy]-3-pyridinyl]-2-methylpropanamide;N-[6-(3-hydroxy-2,2-dimethylpropoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(2-hydroxyethoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxy-3-methylbutoxy)pyrazin-2-yl]-2-methylpropanamide;N-[6-(3-hydroxypropoxy)pyrazin-2-yl]-2-methylpropanamide;2-methyl-N-[5-(1-methylpyrazol-4-yl)-3-pyridinyl]propanamide;2-methyl-N-[5-(2-methyl-1,3-thiazol-5-yl)-3-pyridinyl]propanamide;2-methyl-N-pyrazin-2-ylpropanamide is sourced from PubChem (CID 161103430), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).